K791231

Substantially Equivalent

DAC-CEL T4

Applicant: Burroughs Wellcome Co.
Product code: CDX
Advisory panel: Clinical Chemistry
Date received: 1979-07-02
Decision date: 1979-09-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.